Advertisement
Disease Research
Subscribe to Disease Research

The Lead

Making Lab-Grown Tissues Stronger

October 30, 2014 1:30 pm | News | Comments

Lab-grown tissues could one day provide new treatments for injuries and damage to the joints, including articular cartilage, tendons and ligaments. Read more..                                   

TNIB to Start 90-Day HIV/AIDS Trial in Nigeria

October 30, 2014 1:16 pm | News | Comments

TNI BioTech Inc.,...

‘Treasure in Saliva’ May Reveal Diseases Early Enough to Treat

October 30, 2014 12:34 pm | News | Comments

UCLA research could...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Body Clock Gene May Impact Drug Delivery

October 30, 2014 10:32 am | News | Comments

A new effort mapping 24-hour patterns of expression for thousands of genes in 12 different mouse organs provides important clues about how the role of timing may influence the way drugs work in the body. Read more...        

NeuroDerm Announces Positive Phase 2 Results of Parkinsons Vaccine

October 30, 2014 9:49 am | News | Comments

NeuroDerm announced positive phase 2 results for a new Parkinsons vaccine. Read more...                             

Scientists Aim to Simplify Life Saving Drug

October 30, 2014 9:33 am | News | Comments

A research team from the University of British Columbia has set out to make the use of Heparin a lot safer by developing a universal antidote. Read more...                

Advertisement

Pfizer Gains FDA Approval for Meningococcal B Vaccine

October 30, 2014 9:14 am | News | Comments

Pfizer announced that the FDA has granted accelerated approval of a new meningococcal vaccine. Read more...                          

Where's the Czar? Ebola Raises Management Questions

October 29, 2014 12:40 pm | by Jim Kuhnhenn - Associated Press | News | Comments

Obama is pressing to dispel criticism that the government can't manage the Ebola crisis. Read more...                           

Generic Meds Boost Adherence to Breast Cancer Therapy

October 29, 2014 12:30 pm | News | Comments

 A study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors increased cancer treatment adherence. Read more...             

ESMO: Cancer Immunotherapy on the Road

October 29, 2014 12:20 pm | by Neil Canavan | Articles | Comments

Since cancer immunotherapy was declared the Breakthrough of the Year in 2013 by Science magazine the field has been on fire, and its relatively few experts have been on the run– explaining the nascent technology and related data to oncologists at venues from the April meeting of AACR in San Diego, to the June meeting of ASCO in Chicago, to the September meeting of ESMO in Madrid.  Read more...

Scientists Uncover Major Factor in Development of Huntington's

October 29, 2014 12:16 pm | News | Comments

Scientists from The Scripps Research Institute have uncovered a major contributor to Huntington’s disease. Read more...                        

Advertisement

Pfizer's Antidepressant May Not Affect Sexual Function

October 29, 2014 10:19 am | News | Comments

Pfizer Inc. announced the publication of a clinical study in the Journal of Clinical Psychiatry showing comparable sexual function in adult patients diagnosed with major depressive disorder (MDD) treated daily with Pristiq Extended Release Tablets 50mg and 100mg doses versus placebo. Read more...

Genetic Link to Kidney Stones Identified

October 29, 2014 10:14 am | News | Comments

A new breakthrough could help kidney stone sufferers get an exact diagnosis and specific treatment after genetic links to the condition were identified. Read more...                

Blood Test May Diagnose Early Onset Alzheimer's

October 29, 2014 9:52 am | News | Comments

A non-invasive blood test that could diagnose early onset Alzheimer’s disease with increased accuracy. Read more...                        

Shining Light on Heart Disease Severity, Location

October 28, 2014 1:14 pm | News | Comments

Officials at a life sciences startup based on a Purdue University innovation say their company could help cardiologists improve the diagnosis of heart disease. Read more...                       

Better Chemo Possible Through Targeted Delivery

October 28, 2014 12:38 pm | News | Comments

A new study from MIT, Brigham and Women’s Hospital, and Johns Hopkins University suggests that delivering chemotherapy directly into the brain cavity may offer a better way to treat tumors that have metastasized to the brain. Read more...    

Advertisement

Scripps MS Drug Candidate Shows Promise for UC

October 28, 2014 12:10 pm | News | Comments

Positive new clinical data were released on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute. Read more...              

Swiss Agency Approves Trial for Ebola Vaccine

October 28, 2014 9:56 am | News | Comments

The Swiss agency that regulates new drugs said Tuesday it has approved an application for a clinical trial with an experimental Ebola vaccine. Read more...                 

New Trial Will Explore Heart Disease Prevention in People with HIV

October 28, 2014 9:44 am | News | Comments

The National Institutes of Health and The National Heart, Lung and Blood Institute are initiating a landmark multimillion dollar outcomes trial utilizing pitavastatin for the primary prevention of cardiovascular disease in persons infected with HIV. Read more... 

Drug Combination Shows Promise As Powerful Breast Cancer Treatment

October 28, 2014 9:23 am | News | Comments

Doctors discovered a potent drug combination that shows promise as a powerful treatment for breast cancer. Read more...                        

5,000 Ebola Healthcare Workers Needed in West Africa

October 28, 2014 9:07 am | by Elias Meseret - Associated Press | News | Comments

More than 5,000 additional health care workers are needed to fight Ebola in the three most affected countries in West Africa. Read more...                    

BMS Acquires Worldwide Rights For New Breast Cancer Therapy

October 28, 2014 8:57 am | News | Comments

Bristol-Myers Squibb Company entered into an agreement F-star Alpha to acquire the company and gain worldwide rights to a targeted therapy that can treat breast and gastric cancer. Read more...           

Monitoring Lipid, Detergent Content in Biological Samples Using IR-Based Spectrometry

October 27, 2014 4:01 pm | by Chandreyee Das, Ph.D., Senior Technical Writer, Protein Detection, EMD Millipore | Articles | Comments

Many biological samples in the course of drug development research are rich in lipid content, such as adipose tissue homogenates, brain and liver tissue extracts, lipemic samples and breast milk. Read more...

Merck Announces New Breakthrough Therapy Designation for Lung Cancer

October 27, 2014 1:37 pm | News | Comments

Merck announced that the FDA granted Breakthrough Therapy Designation for the treatment of lung cancer. Read more...                        

Actinium Announces Collaboration Plan on New Program

October 27, 2014 1:23 pm | News | Comments

Actinium Pharmaceuticals and Albert Einstein College of Medicine of Yeshiva University started development of an antibody construct. Read more...                   

Researcher Adapting New Technologies for Fighting Worm Infections

October 27, 2014 1:08 pm | News | Comments

Recent breakthroughs may pave the way for vaccines and new drugs for those infected by parasitic helminths. Read more...                       

Heart Drug May Help Treat ALS, Mouse Study Shows

October 27, 2014 11:46 am | by Michael C. Purdy | News | Comments

Digoxin, a medication used in the treatment of heart failure, may be adaptable for the treatment of ALS, suggests new research at Washington University School of Medicine in St. Louis. Read more...          

Gene Link to Seizures in Children After MMR Vaccine

October 27, 2014 11:08 am | News | Comments

Scientists in Denmark said they had found genetic clues to explain why a small number of children have febrile seizures—brief convulsions—after receiving the measles, mumps and rubella (MMR) vaccine. Read more...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading